Abstract
Macrophage infection by the pathogenic bacteria Yersinia or mimic stimulation of lipopolysaccharide (LPS) and transforming growth factor-β-activated kinase 1 (TAK1) inhibitor or tumor necrosis factor (TNF) and TAK1 inhibitor induces caspase-8-mediated gasdermin D (GSDMD) cleavage and pyroptosis. However, the upstream regulator of caspase-8-dependent cleavage of GSDMD remains elusive. Here we show that Serine/threonine-protein kinase RIO2 (RIOK2) interacts with the Fas-associated protein with death domain (FADD) and is essential for caspase-8-driven GSDMD cleavage. RIOK2's kinase activity drives the transport of lysosome to ER through activating myosin II and thereby translocate FADD-RIPK1-caspase-8 complex from lysosome to ER. Importantly, RIOK2's ATPase activity enhances its binding to this complex and directly triggers caspase-8 and gasdermin D cleavage both at ER and in vitro. Furthermore, RIOK2-mediated pyroptosis enhances host defense against Yersinia infection. Thus, our findings define an upstream regulator of caspase-8-dependent pyroptosis, implying a role of organelle crosstalk in spatial cleavage of gasdermins.
Introduction
Pyroptosis is a highly inflammatory form of programmed cell death critical for innate immune defense. While the canonical pathway involving Caspase-1 is well-characterized, the alternative pathway driven by Caspase-8—often triggered by Yersinia infection or TAK1 inhibition—has lacked a clear upstream regulatory mechanism. Specifically, the spatial coordination required for Caspase-8 to cleave Gasdermin D (GSDMD) was unknown. This study identifies RIOK2, an atypical kinase previously associated with ribosome biogenesis, as a master regulator that manages both the intracellular transport and enzymatic activation of the FADD–RIPK1–Caspase-8 death complex.
Methods and Identification of RIOK2
To identify novel regulators of the Caspase-8 death pathway, researchers performed mass spectrometry on FADD-interacting proteins in HeLa cells overexpressing FLAG-FADD following TNF and TAK1 inhibitor (5z-7) stimulation. RIOK2 emerged as a top candidate with high fold-change abundance and a significant number of peptides, alongside known cell death signaling components like Caspase-8 and GSDMD (Figure 2).
The study further utilized myeloid-specific Riok2 knockout mice (Riok2^fl/fl; Lyz2-Cre) and CRISPR-Cas9-mediated deletion in cell lines to validate these findings. Advanced imaging and organelle fractionation were employed to track the translocation of the death complex from lysosomes to the endoplasmic reticulum (ER).
Results
RIOK2 is Essential for the FADD–RIPK1–Caspase-8 Complex
Biochemical analysis confirmed that RIOK2 directly interacts with FADD. Crucially, the absence of RIOK2 significantly impairs the assembly of the pro-pyroptotic complex. In Riok2-/- macrophages, the recruitment of RIPK1 and Caspase-8 to FADD upon LPS/5z-7 stimulation was markedly reduced compared to wild-type cells, as shown by co-immunoprecipitation assays (Figure 4).
Dual Enzymatic Control of Pyroptosis
The researchers discovered that RIOK2 employs two distinct enzymatic activities to drive cell death:
- Kinase Activity: RIOK2 phosphorylates Myosin II, a motor protein, to facilitate the physical transport of lysosomes (where the complex initially forms) to the ER.
- ATPase Activity: Once at the ER, RIOK2’s ATPase activity strengthens its binding to the complex and directly triggers the cleavage of Caspase-8 and GSDMD.
Physiological Significance
In vivo experiments using Yersinia infection models demonstrated that myeloid-specific RIOK2 deficiency leads to increased bacterial loads in the liver and spleen. This confirms that RIOK2-mediated pyroptosis is a vital component of the host's antibacterial defense. Furthermore, pharmacological inhibition of RIOK2 with the small molecule CQ211 effectively blocked complex translocation and subsequent cell death, highlighting its potential as a therapeutic target for inflammatory disorders.
Discussion and Limitations
This study redefines RIOK2 as a "moonlighting" protein that bridges ribosome biogenesis and innate immunity. By coordinating organelle crosstalk between lysosomes and the ER, RIOK2 ensures the spatial precision of GSDMD cleavage.
However, several questions remain for future investigation. The precise mechanism by which the N-terminal fragment of GSDMD translocates from the ER to the plasma membrane to form pores is not yet fully understood. Additionally, while the role of RIOK2 is clear in macrophages, its function in other cell types remains to be explored. Finally, high-resolution structural studies are needed to elucidate the exact conformational changes induced by RIOK2’s ATPase activity that trigger Caspase-8 activation.
Summary updated